Key Market Indicators
Belgian sales of antidepressant medications are projected to drop to $122 million by 2028, down from $127 million in 2023. This represents an average annual decline of 0.5%. Since 2007, the Belgian market for these drugs has seen a consistent year-on-year decrease of 2.2%. As of 2023, Belgium ranks sixth globally in antidepressant sales, having been overtaken by South Korea, which also recorded $127 million in sales. Spain, Italy, and Australia occupy the second, third, and fourth positions respectively in this ranking.
